BIOPLUS-INTERPHEX KOREA 2026 (BIX 2026) is Korea's largest bio industry event and the country's premier business platform connecting Korea's globally competitive bio-pharmaceutical ecosystem with the international market.
As Korea continues to strengthen its position as a global leader in biopharmaceutical manufacturing, CDMO, biologics, advanced therapies, and biotechnology innovation, BIX 2026 brings together industry leaders, manufacturers, biotech companies, pharmaceutical companies, investors, researchers, and policymakers from around the world.
Covering the entire bio-pharma value chain, the event features more than 35 high-level conference sessions, a comprehensive exhibition, curated business partnering meetings, and extensive networking programs that facilitate meaningful business connections and strategic collaboration.
More than an industry exhibition, BIX is where global companies meet Korea's bio industry to build partnerships, explore investment opportunities, and accelerate business. As Korea's largest and most business-focused bio event, BIX delivers practical opportunities that drive real business outcomes and shape the future of the global bio-pharmaceutical industry.
